English | Español
Patient Daily | Feb 10, 2026

Amgen ends partnership with Kyowa Kirin on autoimmune drug rocatinlimab
Patient Daily | Feb 10, 2026

FDA flagged key issues early before rejecting Corcept’s hypercortisolism drug
Patient Daily | Feb 10, 2026

Sanofi reports mixed phase III results for rare disease drug venglustat
Patient Daily | Feb 10, 2026

Eli Lilly invests $3.5 billion in Pennsylvania obesity drug manufacturing plant
Patient Daily | Feb 10, 2026

GSK ends partnership on WVE-006 for AATD; future collaborations with Wave continue
Patient Daily | Feb 10, 2026

FDA prepares decisions on key therapies from REGENXBIO, Merck, Sanofi/Regeneron
Patient Daily | Feb 10, 2026

Penn Medicine expands holistic cancer care with Whole Person Care Collaborative
Patient Daily | Feb 10, 2026

Penn Medicine study finds rising use of methadone but calls for wider access

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Palbociclib shows promise extending survival in HR+, HER2+ metastatic breast cancer